Search Filters

Search Results

Found 3 results

510(k) Data Aggregation

    K Number
    K060625
    Date Cleared
    2006-04-20

    (42 days)

    Product Code
    Regulation Number
    882.5950
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    NEXUS DETACHABLE COIL SYSTEM, MORPHEUS 3D CSR

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Nexus Detachable Coils are intended for the endovascular embolization of intracranial aneurysms that - because of their morphology, their location, or the patient's general medical condition - are considered by the treating neurosurgical team to be a) very high risk for management by traditional operative techniques, or b) be inoperable. The Nexus Detachable Coils are also intended for the embolization of other neuro vascular abnormalities, such as, arteriovenous malformations and arteriovenous fistulae.

    Device Description

    The Nexus coils are platinum alloy coils, enlaced with absorbable polymer fibers, and attached to a stainless steel guiding system with a radiopaque positioning coil. Nexus coils are designed for use with the NXT Detachment System specifically designed for coil detachment. The NXT Detachment System is sold separately.

    AI/ML Overview

    The provided text describes a medical device, the Nexus Morpheus 3D CSR, and its premarket notification (510(k)) submission to the FDA. The submission focuses on establishing substantial equivalence to a predicate device, the Nexus Tetris 3D CSR, rather than proving the device meets acceptance criteria through a study demonstrating performance metrics in a clinical setting against a defined ground truth.

    Therefore, many of the requested details related to a performance study (like sample size, data provenance, expert ground truth, MRMC study, standalone performance, training set details) are not applicable or not present in the provided document, as it describes a different type of regulatory submission. The verification and test summary focuses on bench testing to ensure the new device functions similarly to the predicate.

    Here's an attempt to answer based on the available information:

    1. Table of Acceptance Criteria and Reported Device Performance

    For this 510(k) submission, the "acceptance criteria" are the established engineering and functional benchmarks for the device, and "reported device performance" indicates whether these benchmarks were met.

    Bench Testing Acceptance CriteriaReported Device Performance
    Coil Deformation met established criteriaMet established criteria
    Dimensional & Visual Analysis met established criteriaMet established criteria
    Ease of Delivery/Coil Frictional Characteristics met established criteriaMet established criteria
    In Vitro Aneurysm Fills and Reliability After Fatigue met established criteriaMet established criteria
    Microfilament Pull-Out met established criteriaMet established criteria
    Tensile Strength met established criteriaMet established criteria

    2. Sample size used for the test set and the data provenance

    The document does not specify sample sizes for these bench tests. The data provenance is internal testing performed by Micro Therapeutics, Inc. (DBA ev3 Neurovascular) on the device components. This is not clinical data, but rather engineering and material testing.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable. Ground truth as typically defined for clinical performance studies (e.g., expert consensus on medical images or pathology results) is not relevant for the bench testing described. The "ground truth" here would be engineering specifications and standards.

    4. Adjudication method for the test set

    Not applicable. This was bench testing against predefined engineering criteria, not a subjective assessment requiring adjudication.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    No. This is a medical device (neurovascular embolization coil), not an AI diagnostic or assistance system. Therefore, an MRMC study related to AI assistance is not applicable.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    No. This is a physical medical device. "Standalone" performance in this context refers to the device's functional integrity during bench testing, not an algorithm's performance.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    The "ground truth" for the bench tests would have been the internal engineering specifications and standards that the device's performance was measured against. This is not clinical ground truth.

    8. The sample size for the training set

    Not applicable. There is no mention of a training set as this is a physical medical device, not a machine learning algorithm.

    9. How the ground truth for the training set was established

    Not applicable, as there is no training set.

    Ask a Question

    Ask a specific question about this device

    K Number
    K051425
    Date Cleared
    2005-06-22

    (21 days)

    Product Code
    Regulation Number
    882.5950
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    NEXUS DETACHABLE COIL SYSTEM, HELIX SUPER SOFT CSR

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Nexus Detachable Coils are intended for the endovascular embolization of intracranial aneurysms that - because of their morphology, their location, or the patient's general medical condition - are considered by the treating neurosurgical team to be a) very high risk for management by traditional operative techniques, or b) be inoperable. The Nexus Detachable Coils are also intended for the embolization of other neuro vascular abnormalities, such as, arteriovenous malformations and arteriovenous fistulae.

    Device Description

    The Nexus Helix Super Soft CSR arc platinum alloy coils, enlaced with absorbable polymer fibers, and attached to a stainless steel guiding system with a radiopaque positioning coil. Nexus Helix Super Soft CSR coils are designed for use with the NXT Detachment System specifically designed for coil detachment. The NXT Detachment System is sold separately.

    AI/ML Overview

    Here's an analysis of the provided text regarding the acceptance criteria and study for the Nexus Helix Super Soft CSR device:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria CategoryAcceptance CriteriaReported Device Performance
    Bench TestingImplicit criteria: Demonstrate equivalence to the predicate device and meet established safety/performance standards for neurovascular embolization devices. Specific quantitative criteria are not detailed in the provided document, but the device must demonstrate comparable performance to the predicate and established norms for safety and efficacy.**Met established criteria for all listed categories:
    Coil Deformation(Implicit: Maintain intended shape and structural integrity under anticipated forces.)Met established criteria
    Dimensional & Visual Analysis(Implicit: Conform to specified dimensions and be free from visual defects.)Met established criteria
    Coating Integrity(Implicit: Maintain a robust and intact coating.)Met established criteria
    Force Transfer(Implicit: Efficiently transfer force for deployment and withdrawal.)Met established criteria
    Ease of Delivery/Coil Frictional Characteristics(Implicit: Demonstrate smooth and controlled delivery with acceptable frictional properties.)Met established criteria
    Fiber Endurance Testing(Implicit: Fibers, if present, must withstand expected stresses over time.)Met established criteria
    Reliability After Fatigue & Premature Detachment(Implicit: Maintain integrity and prevent premature detachment after simulated fatigue.)Met established criteria
    Fiber Pull-Out(Implicit: Fibers must remain securely attached to the coil structure.)Met established criteria
    Tensile Strength(Implicit: Possess adequate tensile strength for handling and deployment.)Met established criteria
    Particulate Generation – Adjusted Particles / 1 mL(Implicit: Generate minimal and acceptable levels of particulates to prevent adverse events.)Met established criteria
    PGLA Tensile Testing(Implicit: If PGLA is used, its tensile properties must meet standards.)Met established criteria
    Packaging Integrity(Implicit: Packaging must maintain sterility and protect the device.)Met established criteria
    Overall Substantial Equivalence to Predicate DeviceSame intended use, same operating principle, same basic design, similar construction and material, packaged and sterilized using same processes.The data presented demonstrates technological similarity and is actively compared with the predicate device Nexus Detachable Coils, leading to an opinion of substantial equivalence.

    Study Details:

    The provided document describes a Special 510(k) submission for the Nexus Helix Super Soft CSR device. This type of submission relies on the concept of substantial equivalence to a previously cleared predicate device (K050543, Nexus Detachable Coil System). Therefore, the "study" is primarily a bench testing and comparative analysis rather than a full-scale clinical trial.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size for Test Set: The document does not specify the sample size used for each bench test. It merely states that the tests "Met established criteria."
    • Data Provenance: The data provenance is from Micro Therapeutics, Inc., the manufacturer. It is retrospective in the sense that the testing was conducted by the manufacturer for the purpose of the 510(k) submission, likely in a controlled laboratory setting. No country of origin for the data is explicitly mentioned beyond the company's address in Irvine, California, USA.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    • Experts and Qualifications: This information is not provided in the document. For bench testing, "ground truth" is typically established by engineering specifications, validated test methods, and industry standards, rather than expert consensus in the clinical sense. The "established criteria" would have been determined by the manufacturer based on these engineering and regulatory requirements.

    4. Adjudication Method for the Test Set

    • Adjudication Method: This information is not applicable/provided. Bench testing results are typically objectively measured against pre-defined engineering criteria, not adjudicated by a panel in the way clinical study outcomes might be.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • MRMC Study: No, an MRMC comparative effectiveness study was not done. This document describes the clearance of a physical medical device (neurovascular embolization coils) through a 510(k) pathway, which primarily relies on bench testing and comparison to an existing predicate device. It is not an AI-assisted diagnostic or imaging device, so MRMC studies involving human readers and AI assistance are irrelevant to this submission.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • Standalone Performance: Not applicable. This device is a physical embolization coil, not an algorithm or AI system. Therefore, standalone algorithm performance is not relevant.

    7. The Type of Ground Truth Used

    • Ground Truth Type: The "ground truth" for the bench tests is the pre-established engineering specifications, performance standards, and safety requirements for neurovascular embolization devices, as well as the performance characteristics of the predicate device. These are derived from a combination of scientific principles, regulatory guidelines, and industry best practices.

    8. The Sample Size for the Training Set

    • Sample Size for Training Set: Not applicable. This device is not an AI/machine learning model that requires a "training set." The development of the device would involve engineering design and iterative testing, but not in the context of a "training set" for an algorithm.

    9. How the Ground Truth for the Training Set was Established

    • Ground Truth for Training Set Establishment: Not applicable. As explained above, there is no "training set" in the context of this device and submission type.
    Ask a Question

    Ask a specific question about this device

    K Number
    K050543
    Date Cleared
    2005-04-27

    (56 days)

    Product Code
    Regulation Number
    882.5950
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    NEXUS DETACHABLE COIL SYSTEM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Nexus Detachable Coils are intended for the endovascular embolization of intracranial aneurysms that -- because of their morphology, their location, or the patient's general medical condition - are considered by the treating neurosurgical team to be a) very high risk for management by traditional operative techniques, or b) be inoperable. The Nexus Detachable Coils are also intended for the embolization of other neuro vascular abnormalities, such as, arteriovenous malformations and arteriovenous fistulae.

    Device Description

    The Nexus™ Detachable Coil are platinum alloy coils, enlaced with absorbable polymer fibers, and attached to a stainless steel guiding system with a radiopaque positioning coil. Nexus™ Detachable Coils are designed for use with the NXT Detachment System, specifically designed for coil detachment. The NXT Detachment System is sold separately.

    AI/ML Overview

    Here's an analysis of the provided text regarding the acceptance criteria and study for the Nexus Detachable Coil System:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria (Bench Testing)Reported Device Performance
    Coil DeformationMet established criteria
    Dimensional & Visual AnalysisMet established criteria
    Coating IntegrityMet established criteria
    Force TransferMet established criteria
    Ease of Delivery/Coil Frictional CharacteristicsMet established criteria
    Fiber Endurance TestingMet established criteria
    Reliability After Fatigue & Premature DetachmentMet established criteria
    Fiber Pull-OutMet established criteria
    Tensile StrengthMet established criteria
    Particulate Generation -- Adjusted Particles / 1 mLMet established criteria
    PGLA Tensile TestingMet established criteria
    Packaging IntegrityMet established criteria

    2. Sample Size Used for the Test Set and Data Provenance

    The document only mentions "Bench Testing" and states that a variety of tests were conducted. It does not specify the sample size used for individual tests, nor does it provide information on data provenance (e.g., country of origin, retrospective/prospective). These appear to be laboratory-based engineering tests, not clinical studies involving human or animal subjects.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    This information is not provided. Since the testing described is primarily bench testing for mechanical and material properties, it's unlikely that "experts" in the sense of medical professionals were establishing ground truth for these specific tests. Instead, the "ground truth" would be established by engineering specifications and industry standards.

    4. Adjudication Method for the Test Set

    This information is not provided. Given the nature of the bench testing, an adjudication method typically used in clinical studies (like 2+1) is not applicable. The results would likely be determined by meeting predefined engineering specifications.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    No, an MRMC comparative effectiveness study was not done. The submission focuses on demonstrating substantial equivalence through bench testing and comparison to predicate devices, not on comparing human reader performance with or without AI assistance.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    No, a standalone (algorithm only) performance assessment was not done. The Nexus Detachable Coil System is a physical medical device, not an AI or software algorithm.

    7. The Type of Ground Truth Used

    The ground truth for the "acceptance criteria" presented appears to be based on established engineering specifications, material standards, and performance benchmarks derived from the predicate devices. The document states "Met established criteria" for each test, implying that there were pre-defined quantitative or qualitative criteria for success.

    8. The Sample Size for the Training Set

    This concept is not applicable to this submission. The Nexus Detachable Coil System is a physical device, not an AI model that requires a "training set."

    9. How the Ground Truth for the Training Set Was Established

    This concept is not applicable to this submission, as there is no "training set" for this physical medical device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1